Cataract
Conditions
Brief summary
The aim of the current intervention study is to determine the effectiveness of taurine containing eye drops (available under brand name VIZILOTON) to prevent the progression of grade I and II senile cataract. This study could answer: * Dose continuous use of taurine-containing eye drops could prevent further deterioration of vision in mild cases of cataract? * The acceptance/ compliance of participants to taurine-containing eye drops. * Could long-term use of taurine-containing eye drops cause adverse effect(s)? Participants will: * Take taurine-containing eye drops (VIZILOTON eye drops) 4 times a day for one year. * Visit eye clinic every 3 months for assessment and visual examination. * Keep notes for their symptoms and their adherence to treatment.
Interventions
DRUGTaurine
Taurine-containing eye drops (VIZILOTON) are applied 4 times daily for a period of one year
Sponsors
University Of Anbar
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
single-arm pre-post intervention study
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The presence of grade I or II senile cataract on one or two eyes.
Exclusion criteria
* clinical signs of glaucoma * history of amblyopia, eye surgery, argon or YAG laser eye treatment, or major eye trauma * history of iritis, retinal crystalline deposits, or optic nerve disease * visually significant fundus pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Acuity | 1 Year |
Countries
Iraq
Outcome results
None listed